Spots Global Cancer Trial Database for Analysis of Screen-detected Lung Cancers' Genomic Traits

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Analysis of Screen-detected Lung Cancers' Genomic Traits

Official Title: Analysis of Screen-detected Lung Cancers' Genomic Traits

Study ID: NCT04204499

Conditions

Lung Cancer

Interventions

Study Description

Brief Summary: Prospective, observational cohort study of patients undergoing surgical resection for low dose CT (LDCT) screen-detected lung cancer (detected through the SUMMIT study- ClinicalTrials.gov Identifier: NCT03934866/ lung screening programmes), in which translational research is a fundamental aspect.

Detailed Description: The ASCENT study seeks to examine the genomic signatures of screen-detected cancers, in order to categorise the biological behaviour of such lesions and correlate this against non-invasive biological and radiological parameters. From these data, the plan is to explore strategies to characterise LDCT-detected cancers through non-invasive means, which the researchers believe may prove key in mitigating potential screening-associated harms.